secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001437749-24-037350
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 3.03, 5.07, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve merger with Palvella; authorized shares increased 53x to 200M
--------------------------------------------------------------------------------

- Merger expected to close Dec. 13; pre-merger stockholders receive Contingent Value Rights.
- Authorized shares increased from 3.75M to 200M; Series F Preferred redeemed for $0.01.
- Proposal to issue shares in merger approved: 718,345 for, 4,199 against, 294,890 broker non-votes.
- Name change to Palvella Therapeutics, Inc. and 2024 Equity Incentive Plan approved.
- All proposals approved by requisite votes; no adjournment needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/0001437749-24-037350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924037350/pirs20241115c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-037350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer